President Donald Trump's fiscal 2018 budget proposal would cut FDA's human drug program by $307 million in discretionary budget authority, its medical device program by $182 million, its biologics program by $119 million and its food program by $70 million, resulting in cuts to the agency's workforce and programs even if Congress were to go along with Trump's request to double user fees. FDA would cut back its workforce through attrition, reevaluate how it deals with device post-market surveillance, issue...